Lexaria Bioscience's top three insider shareholders as of March 23, 2026 are Richard Christopher (Chief Executive Officer, 65.00K shares), William Edward Mckechnie (Director, 18.19K shares), Albert L Jr Reese (Director, 10.92K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Christopher Bunka | 0 | 281,912 | 30 Jul, 2025 | |
| Christopher Bunka | 273,543 | 0 | 18 Mar, 2026 | |
| Richard Christopher | Chief Executive Officer | 65,000 | 0 | 30 Jul, 2025 |
| William Edward Mckechnie | 18,191 | 0 | 30 Jul, 2025 | |
| Albert L Jr Reese | 10,917 | 0 | 25 May, 2022 | |
| John Martin Docherty | President Cso | 5,376 | 0 | 30 Jul, 2025 |
| Catherine C. Turkel | 3,100 | 0 | 13 Aug, 2024 | |
| Gregory Downey | Chief Financial Officer | 1,954 | 0 | 18 Oct, 2022 |
| Vanessa Carle | Secretary | 750 | 0 | 30 Jul, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Christopher Bunka | common shares | D | 100,000 | $0.00 | 273,543 | D | G |
| 29 Jul, 2025 | Vanessa Carle | common shares | A | 750 | $0.91 | 750 | D | P |
| 29 Jul, 2025 | William Edward Mckechnie | common shares | A | 5,000 | $0.91 | 18,191 | D | P |
| 29 Jul, 2025 | Richard Christopher | common shares | A | 15,000 | $0.91 | 65,000 | D | P |
| 29 Jul, 2025 | John Martin Docherty | common shares | A | 5,376 | $0.93 | 5,376 | D | P |
| 29 Jul, 2025 | Christopher Bunka | common shares | A | 15,600 | $0.92 | 270,012 | I | P |
| 30 Jul, 2025 | Christopher Bunka | common shares | A | 11,900 | $0.91 | 281,912 | I | P |
| 15 May, 2025 | Michael Elliot Shankman | Stock Options | A | 50,000 | $0.00 | 100,000 | D | A |
| 15 May, 2025 | Baljinder Bhullar | Stock Options | A | 11,000 | $0.00 | 11,000 | D | A |
| 15 May, 2025 | Richard Christopher | Stock Options | A | 150,000 | $0.00 | 350,000 | D | A |
| 15 May, 2025 | Vanessa Carle | Stock Options | A | 15,000 | $0.00 | 75,000 | D | A |
| 15 May, 2025 | John Martin Docherty | Stock Options | A | 150,000 | $0.00 | 310,834 | D | A |
| 15 May, 2025 | Albert L Jr Reese | Stock Options | A | 11,000 | $0.00 | 43,000 | D | A |
| 15 May, 2025 | Christopher Bunka | Stock Options | A | 11,000 | $0.00 | 184,834 | D | A |
| 15 May, 2025 | William Edward Mckechnie | Stock Options | A | 11,000 | $0.00 | 63,000 | D | A |
| 15 May, 2025 | Nicholas W Baxter | Stock Options | A | 11,000 | $0.00 | 63,000 | D | A |
| 07 Jan, 2025 | Christopher Bunka | Restricted Stock Award | A | 100,000 | $0.00 | 373,543 | D | A |
| 02 Dec, 2024 | Richard Christopher | common shares | A | 22,828 | $2.24 | 22,828 | D | P |
| 03 Dec, 2024 | Richard Christopher | common shares | A | 27,172 | $2.47 | 50,000 | D | P |
| 12 Aug, 2024 | Catherine C. Turkel | common shares | A | 1,600 | $3.13 | 3,100 | D | P |